Therapeutic Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Althea Med J [Internet]. 2025 Sep. 30 [cited 2026 Jul. 18];12(3):161-7. Available from: https://journal.fk.unpad.ac.id/index.php/amj/article/view/4209